Nuvalent Inc - Class A — Balance Sheet (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 293.82 M482.46 M732.38 M1.14 B1.41 B Total liabilities 8.79 M19.48 M31.82 M71.96 M164.37 M Total equity 285.04 M462.98 M700.56 M1.07 B1.25 B Total liabilities & shareholders' equities 293.82 M482.46 M732.38 M1.14 B1.41 B Total debt ————— Net debt —————

新闻

Nuvalent公布第四季度亏损,等待FDA对肺癌药物的决定

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Nuvalent Inc股票触及52周高点112.89美元

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA接受Nuvalent针对ROS1阳性非小细胞肺癌治疗的新药申请

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts